Palvella Therapeutics (PVLA) Net Cash Flow (2013 - 2026)
Palvella Therapeutics (PVLA) reported Net Cash Flow of $148.4 million for Q1 2026, up 1961.87% year-over-year from $7.2 million in Q1 2025, and up 3086.34% on a QoQ basis from -$5.0 million in Q4 2025.
Palvella Therapeutics (PVLA) has 14 years of Net Cash Flow data on file, last reported at $148.4 million in Q1 2026.
- Quarterly Net Cash Flow rose 1961.87% year-over-year to $148.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $130.7 million (up 82.29% YoY) and the FY2025 annual result came in at -$25.7 million, down 133.65% from the prior year.
- Net Cash Flow rose to $148.4 million in Q1 2026 per PVLA's latest filing, from -$5.0 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $148.4 million in Q1 2026 and bottomed at -$33.0 million in Q1 2022.
- The 5-year median for Net Cash Flow is -$3.0 million (2022), against an average of $8.2 million.
- The widest annual swing landed in 2025, when Net Cash Flow tumbled 3962.77%; it then jumped 1961.87% in 2026.
- Tracing PVLA's Net Cash Flow over 5 years: stood at -$11.7 million in 2022, then soared by 177.69% to $9.1 million in 2023, then soared by 661.29% to $69.4 million in 2024, then slumped by 107.16% to -$5.0 million in 2025, then jumped by 3086.34% to $148.4 million in 2026.
- Per Business Quant, the three latest PVLA Net Cash Flow figures stand at $148.4 million (Q1 2026), -$5.0 million (Q4 2025), and -$7.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 625.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 457.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -152.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 60.68 Mn |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - | 148.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 148.39 Mn |
| Mar 31, 2026 | 148.39 Mn |
| Dec 31, 2025 | -4.97 Mn |
| Dec 31, 2025 | -4.97 Mn |
| Sep 30, 2025 | -7.64 Mn |
| Sep 30, 2025 | -7.64 Mn |
| Jun 30, 2025 | -5.08 Mn |
| Jun 30, 2025 | -5.08 Mn |
| Mar 31, 2025 | -7.97 Mn |
| Mar 31, 2025 | -7.97 Mn |
| Dec 31, 2024 | 69.39 Mn |
| Dec 31, 2024 | 69.39 Mn |
| Sep 30, 2024 | -188,000.00 |
| Sep 30, 2024 | -188,000.00 |
| Jun 30, 2024 | 10.47 Mn |
| Jun 30, 2024 | 10.47 Mn |
| Mar 31, 2024 | 7.90 Mn |
| Mar 31, 2024 | 7.90 Mn |
| Dec 31, 2023 | 9.12 Mn |
| Dec 31, 2023 | 9.12 Mn |
| Sep 30, 2023 | -11.71 Mn |
| Sep 30, 2023 | -11.71 Mn |
| Jun 30, 2023 | 4.98 Mn |
| Jun 30, 2023 | 4.98 Mn |
| Mar 31, 2023 | 907,000.00 |
| Mar 31, 2023 | 907,000.00 |
| Dec 31, 2022 | -11.73 Mn |
| Dec 31, 2022 | -11.73 Mn |
| Sep 30, 2022 | -3.03 Mn |
| Sep 30, 2022 | -3.03 Mn |
| Jun 30, 2022 | -26.16 Mn |
| Jun 30, 2022 | -26.16 Mn |
| Mar 31, 2022 | -33.03 Mn |
| Mar 31, 2022 | -33.03 Mn |
| Dec 31, 2021 | -6.39 Mn |
| Dec 31, 2021 | -6.39 Mn |
| Sep 30, 2021 | 7.08 Mn |
| Sep 30, 2021 | 7.08 Mn |
| Jun 30, 2021 | 52.29 Mn |
| Jun 30, 2021 | 52.29 Mn |
| Mar 31, 2021 | -2.47 Mn |
| Mar 31, 2021 | -2.47 Mn |
| Dec 31, 2020 | 1.51 Mn |
| Dec 31, 2020 | 1.51 Mn |
| Sep 30, 2020 | 20.41 Mn |
| Sep 30, 2020 | 20.41 Mn |
| Jun 30, 2020 | -3.77 Mn |
| Jun 30, 2020 | -3.77 Mn |
| Mar 31, 2020 | -14.72 Mn |
| Mar 31, 2020 | -14.72 Mn |
| Dec 31, 2019 | 15.81 Mn |
| Dec 31, 2019 | 15.81 Mn |
| Sep 30, 2019 | -8.31 Mn |
| Sep 30, 2019 | -8.31 Mn |
| Jun 30, 2019 | 2.46 Mn |
| Jun 30, 2019 | 2.46 Mn |
| Mar 31, 2019 | -20.42 Mn |
| Mar 31, 2019 | -20.42 Mn |
| Dec 31, 2018 | -14.27 Mn |
| Dec 31, 2018 | -14.27 Mn |
| Sep 30, 2018 | 39.32 Mn |
| Sep 30, 2018 | 39.32 Mn |
| Jun 30, 2018 | -57.68 Mn |
| Jun 30, 2018 | -57.68 Mn |
| Mar 31, 2018 | 71.21 Mn |
| Mar 31, 2018 | 71.21 Mn |
| Dec 31, 2017 | -48.84 Mn |
| Dec 31, 2017 | -48.84 Mn |
| Sep 30, 2017 | 36.94 Mn |
| Sep 30, 2017 | 36.94 Mn |
| Jun 30, 2017 | -5.72 Mn |
| Jun 30, 2017 | -5.72 Mn |
| Mar 31, 2017 | 25.59 Mn |
| Mar 31, 2017 | 25.59 Mn |
| Dec 31, 2016 | -6.97 Mn |
| Dec 31, 2016 | -6.97 Mn |
| Sep 30, 2016 | -3.83 Mn |
| Sep 30, 2016 | -3.83 Mn |
| Jun 30, 2016 | 9.11 Mn |
| Jun 30, 2016 | 9.11 Mn |
| Mar 31, 2016 | 1.96 Mn |
| Mar 31, 2016 | 1.96 Mn |
| Dec 31, 2015 | -2.83 Mn |
| Dec 31, 2015 | -2.83 Mn |
| Sep 30, 2015 | 22.05 Mn |
| Sep 30, 2015 | 22.05 Mn |
| Jun 30, 2015 | -3.16 Mn |
| Jun 30, 2015 | -3.16 Mn |
| Mar 31, 2015 | -4.76 Mn |
| Mar 31, 2015 | -4.76 Mn |
| Sep 30, 2014 | -25,229.00 |
| Sep 30, 2014 | -25,229.00 |
| Jun 30, 2014 | -2.19 Mn |
| Jun 30, 2014 | -2.19 Mn |
| Mar 31, 2014 | -419,845.00 |
| Mar 31, 2014 | -419,845.00 |
| Dec 31, 2013 | 652.00 |
| Dec 31, 2013 | 652.00 |
| Sep 30, 2013 | -4,512.00 |
| Sep 30, 2013 | -4,512.00 |
| Jun 30, 2013 | 5,200.00 |
| Jun 30, 2013 | 5,200.00 |